Krämer, J., Tenberge, J., Kleiter, I., Gaissmaier, W., Ruck, T., Heesen, C., & Meuth, S. G. (2017). Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis? PLoS One.

Krämer, Julia, Jan-Gerd Tenberge, Ingo Kleiter, Wolfgang Gaissmaier, Tobias Ruck, Christoph Heesen, e Sven G. Meuth. "Is the Risk of Progressive Multifocal Leukoencephalopathy the Real Reason for Natalizumab Discontinuation in Patients With Multiple Sclerosis?" PLoS One 2017.

Krämer, Julia, et al. "Is the Risk of Progressive Multifocal Leukoencephalopathy the Real Reason for Natalizumab Discontinuation in Patients With Multiple Sclerosis?" PLoS One 2017.